Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities URGN - UroGen Pharma Ltd.
117 M
LAST VALUE
27.16%
2 YEAR CAGR
11.98%
5 YEAR CAGR
42.16%
10 YEAR CAGR